Globus Medical, Inc. (GMED)
70.53
+0.54
(+0.77%)
USD |
NYSE |
Nov 18, 16:00
70.55
+0.02
(+0.03%)
After-Hours: 20:00
Globus Medical Enterprise Value : 8.948B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 8.948B |
| November 17, 2026 | 8.876B |
| November 16, 2026 | 8.944B |
| November 13, 2026 | 9.161B |
| November 12, 2026 | 9.182B |
| November 11, 2026 | 9.592B |
| November 10, 2026 | 9.571B |
| November 09, 2026 | 9.722B |
| November 06, 2026 | 9.017B |
| November 05, 2026 | 10.40B |
| November 04, 2026 | 11.15B |
| November 03, 2026 | 10.15B |
| November 02, 2026 | 10.13B |
| October 30, 2026 | 9.945B |
| October 29, 2026 | 10.59B |
| October 28, 2026 | 10.37B |
| October 27, 2026 | 10.32B |
| October 26, 2026 | 10.45B |
| October 23, 2026 | 10.39B |
| October 22, 2026 | 10.42B |
| October 21, 2026 | 10.03B |
| October 20, 2026 | 10.07B |
| October 19, 2026 | 9.627B |
| October 16, 2026 | 9.768B |
| October 15, 2026 | 10.05B |
| Date | Value |
|---|---|
| October 14, 2026 | 9.714B |
| October 13, 2026 | 9.716B |
| October 12, 2026 | 9.705B |
| October 09, 2026 | 9.494B |
| October 08, 2026 | 9.319B |
| October 07, 2026 | 9.375B |
| October 06, 2026 | 9.730B |
| October 05, 2026 | 9.749B |
| October 02, 2026 | 9.620B |
| October 01, 2026 | 9.462B |
| September 30, 2026 | 9.527B |
| September 29, 2026 | 9.678B |
| September 28, 2026 | 9.556B |
| September 25, 2026 | 9.521B |
| September 24, 2026 | 9.488B |
| September 23, 2026 | 9.446B |
| September 22, 2026 | 9.611B |
| September 21, 2026 | 9.490B |
| September 18, 2026 | 9.462B |
| September 17, 2026 | 9.473B |
| September 16, 2026 | 9.621B |
| September 15, 2026 | 9.544B |
| September 14, 2026 | 9.689B |
| September 11, 2026 | 9.477B |
| September 10, 2026 | 9.392B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 208.41B |
| Becton, Dickinson & Co. | 74.19B |
| Merit Medical Systems, Inc. | 5.463B |
| Teleflex, Inc. | 7.955B |
| Glaukos Corp. | 13.56B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 141.17M |
| Revenue (Quarterly) | 763.72M |
| Total Expenses (Quarterly) | 622.55M |
| EPS Diluted (Quarterly) | 1.038 |
| Gross Profit Margin (Quarterly) | 65.63% |
| Profit Margin (Quarterly) | 18.48% |
| Earnings Yield | 5.77% |
| Operating Earnings Yield | 7.46% |
| Normalized Earnings Yield | 6.050 |